FDA Set to Review Moderna’s mFlusiva mRNA Flu Shot
An mRNA (messenger ribonucleic acid) influenza biologic developed by Moderna, Inc. is scheduled to be reviewed today by a U.S. Food and Drug Administration (FDA) advisory panel. The Vaccines and Related Biological Products Advisory Committee ((VRBPAC) will evaluate data on Moderna’s mFlusiva (formerly known as mRNA-1010) to determine if the product provides superior relative vaccine […]
Nomination of Susan Monarez for CDC Director Advances to Full Senate
(photo courtesy ARPA-H) On July 9, 2025, the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) voted 12 to 11 to advance the nomination of Susan Monarez to be director of the Centers for Disease Control and Prevention (CDC). Monarez, who holds a doctorate degree in microbiology and immunology and has been serving […]
FDA Ordered to Release Data on Emergency Use Authorization of COVID-19 Shots
The U.S. Food and Drug Administration (FDA) has been ordered to disclose data it relied on when authorizing COVID-19 shots. U.S. District Court Judge Mark Pittman in Fort Worth, Texas ordered the FDA to release their file on “emergency use authorization” (EUA) related to the Pfizer/BioNTech Comirnaty COVID biologic to a group of scientists. Accordingly, […]
CDC’s Independence, Integrity Compromised by Funding from Private Industry
On its website, the U.S. Centers for Disease Control and Prevention (CDC) boasts a “Pledge to the American People” that outlines five commitments. Among these commitments is one to place the benefits to society above the benefits to the government agency. This prohibits employees “from participating in matters that post a conflict of interest or […]
U.S. Government is Funding Gain-of-Function Research in China to Make Bird Flu More Infectious
The U.S government is again funding gain-of-function (GoF) research with Chinese scientists to make a dangerous virus even more potent. This time it is with birds not bats. The U.S. Department of Agriculture (USDA) gave $1 million to fund risky research on bird flu viruses to the Chinese Academy of Sciences in Beijing, China; the […]
FDA Panel Statements Prompt Pharmacies to Pull Popular Nasal Decongestants from Pharmacy Shelves
Conventional over-the-counter cold meds promise cold symptom relief right on the front of their packaging, but U.S. Food and Drug Administration (FDA) advisors have stated that an active ingredient in many popular cold medicines is not effective in relieving congestion when taken orally. An advisory panel for the FDA unanimously concluded recently that phenylephrine, a […]